TY - JOUR
T1 - Comprehensive Analysis of Familial Parkinsonism Genes in Rapid-Eye-Movement Sleep Behavior Disorder
AU - Mufti, Kheireddin
AU - Rudakou, Uladzislau
AU - Yu, Eric
AU - Krohn, Lynne
AU - Ruskey, Jennifer A.
AU - Asayesh, Farnaz
AU - Laurent, Sandra B.
AU - Spiegelman, Dan
AU - Arnulf, Isabelle
AU - Hu, Michele T.M.
AU - Montplaisir, Jacques Y.
AU - Gagnon, Jean François
AU - Desautels, Alex
AU - Dauvilliers, Yves
AU - Gigli, Gian Luigi
AU - Valente, Mariarosaria
AU - Janes, Francesco
AU - Högl, Birgit
AU - Stefani, Ambra
AU - Holzknecht, Evi
AU - Šonka, Karel
AU - Kemlink, David
AU - Oertel, Wolfgang
AU - Janzen, Annette
AU - Plazzi, Giuseppe
AU - Antelmi, Elena
AU - Figorilli, Michela
AU - Puligheddu, Monica
AU - Mollenhauer, Brit
AU - Trenkwalder, Claudia
AU - Sixel-Döring, Friederike
AU - Cochen De Cock, Valérie
AU - Monaca, Christelle Charley
AU - Heidbreder, Anna
AU - Ferini-Strambi, Luigi
AU - Dijkstra, Femke
AU - Viaene, Mineke
AU - Abril, Beatriz
AU - Boeve, Bradley F.
AU - Postuma, Ronald B.
AU - Rouleau, Guy A.
AU - Gan-Or, Ziv
N1 - Funding Information:
J.‐F.G. holds a Canada Research Chair in cognitive decline in pathological aging. W.O. is Hertie senior research professor, supported by the Hertie Foundation. E.A.F. holds a Canada Research Chair (Tier 1) in PD. G.A.R. holds a Canada Research Chair (Tier 1) in genetics of the nervous system and the Wilder Penfield Chair in neurosciences. Z.G.‐O. is supported by the Fonds de recherche du Québec–Santé Chercheur‐Boursier award and is a Parkinson Canada New Investigator awardee. We thank the participants for their contribution to the study. We thank D. Rochefort, H. Catoire, and V. Zaharieva for their assistance.
Funding Information:
This work was financially supported by the Michael J. Fox Foundation; the Canadian Consortium on Neurodegeneration in Aging (CCNA); Parkinson Canada; and the Canada First Research Excellence Fund (CFREF), awarded to McGill University for the Healthy Brains for Healthy Lives (HBHL) program. The Montreal cohort was funded by the Canadian Institutes of Health Research (CIHR) and the W. Garfield Weston Foundation. The Oxford Discovery study was funded by the Monument Trust Discovery Award from Parkinson's UK and supported by the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre based at Oxford University Hospitals NHS Trust and University of Oxford, the NIHR Clinical Research Network and the Dementias and Neurodegenerative Diseases Research Network (DeNDRoN). Funding agencies:
Funding Information:
J.-F.G. holds a Canada Research Chair in cognitive decline in pathological aging. W.O. is Hertie senior research professor, supported by the Hertie Foundation. E.A.F. holds a Canada Research Chair (Tier 1) in PD. G.A.R. holds a Canada Research Chair (Tier 1) in genetics of the nervous system and the Wilder Penfield Chair in neurosciences. Z.G.-O. is supported by the Fonds de recherche du Qu?bec?Sant? Chercheur-Boursier award and is a Parkinson Canada New Investigator awardee. We thank the participants for their contribution to the study. We thank D. Rochefort, H. Catoire, and V. Zaharieva for their assistance.
Publisher Copyright:
© 2020 International Parkinson and Movement Disorder Society
PY - 2021/1
Y1 - 2021/1
N2 - Background: There is only partial overlap in the genetic background of isolated rapid-eye-movement sleep behavior disorder (iRBD) and Parkinson's disease (PD). Objective: To examine the role of autosomal dominant and recessive PD or atypical parkinsonism genes in the risk of iRBD. Methods: Ten genes, comprising the recessive genes PRKN, DJ-1 (PARK7), PINK1, VPS13C, ATP13A2, FBXO7, and PLA2G6 and the dominant genes LRRK2, GCH1, and VPS35, were fully sequenced in 1039 iRBD patients and 1852 controls of European ancestry, followed by association tests. Results: We found no association between rare heterozygous variants in the tested genes and risk of iRBD. Several homozygous and compound heterozygous carriers were identified, yet there was no overrepresentation in iRBD patients versus controls. Conclusion: Our results do not support a major role for variants in these genes in the risk of iRBD.
AB - Background: There is only partial overlap in the genetic background of isolated rapid-eye-movement sleep behavior disorder (iRBD) and Parkinson's disease (PD). Objective: To examine the role of autosomal dominant and recessive PD or atypical parkinsonism genes in the risk of iRBD. Methods: Ten genes, comprising the recessive genes PRKN, DJ-1 (PARK7), PINK1, VPS13C, ATP13A2, FBXO7, and PLA2G6 and the dominant genes LRRK2, GCH1, and VPS35, were fully sequenced in 1039 iRBD patients and 1852 controls of European ancestry, followed by association tests. Results: We found no association between rare heterozygous variants in the tested genes and risk of iRBD. Several homozygous and compound heterozygous carriers were identified, yet there was no overrepresentation in iRBD patients versus controls. Conclusion: Our results do not support a major role for variants in these genes in the risk of iRBD.
KW - REM sleep behavior disorder; genetic analysis; Parkinson's disease
UR - http://www.scopus.com/inward/record.url?scp=85091797307&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85091797307&partnerID=8YFLogxK
U2 - 10.1002/mds.28318
DO - 10.1002/mds.28318
M3 - Article
C2 - 33001463
AN - SCOPUS:85091797307
SN - 0885-3185
VL - 36
SP - 235
EP - 240
JO - Movement Disorders
JF - Movement Disorders
IS - 1
ER -